Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a weekend retreat help prevent suicide in women veterans?

NCT ID NCT07738445

Prevention Sponsor: VA Office of Research and Development Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This pilot study tests a 3-day retreat program called GRIT, designed for women veterans who have experienced violence. The goal is to see if the retreat is acceptable and feasible, and whether it can improve social functioning as a way to reduce suicide risk. Participants are randomly assigned to either the in-person retreat or a self-guided version of the program. The study will compare outcomes like satisfaction, loneliness, and social functioning between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
GRIT, a 3-day in-person group retreat program
What this could lead to
If successful, this retreat-based program could offer a new way to reduce suicide risk by improving social connections among women veterans who have experienced violence.
What could go wrong
This is a small pilot study, so results may not apply broadly. The program's benefits are uncertain, and participation requires a significant time commitment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 48 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Dec 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a US federal agency other than the NIH.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Experienced interpersonal violence as evidenced by endorsement of items 6, 7, 8, 9, or 11 from the Life Events Checklist for DSM-5® 2. Are willing and able to participate in a two overnight, three-day, retreat and complete pre- and post-retreat surveys 3. Are actively engaged in VHA mental healthcare (i.e., have a documented mental health visit with a VA provider within the last 90 days 4. Endorse some difficulties in social functioning as indicated by a score \>2 on at least two items of the social functioning questionnaire 5. Ability to speak, read, and understand spoken English sufficiently well to complete the procedures of the study 6. Have access to a mobile phone or computer device that will enable participation in virtual video sessions Exclusion Criteria: 1. Current suicidal thoughts and intent (using the Columbia Suicide Severity Rating Scale; C-SSRS, (i.e., endorses items 1, 2, and 4 or 5) 2. Diagnosis of alcohol or substance use dependence in medical record. In cases where alcohol or substance use is identified as problematic but not reaching the threshold for diagnosis of SUD dependence, additional consultation with mental health providers and chart review by the PI will be used to determine suitability for participation 3. Current psychosis or mania as indicated by electronic health records, or as identified during baseline administration of Quick SCID

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Suicide prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Suicide Prevention

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Suicide prevention

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Providence VA Medical Center, Providence, RI

    Providence, Rhode Island, 02908-4734, United States

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut, 06516-2770, United States

  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT

    West Haven, Connecticut, 06516-2770, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.